Transaction #23317 · Form 4 · 0002064982-25-000003
Tvardi Therapeutics, Inc. · Stock award · Employee Stock Option (right to buy)
Tvardi Therapeutics, Inc. · Transacted December 16, 2025 · Filed December 18, 2025
What does this filing report?
An SEC Form 4 filing for Tvardi Therapeutics, Inc. records a stock award involving Employee Stock Option (right to buy) on December 16, 2025. The reported quantity was 17,500. The filing date is December 18, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Tvardi Therapeutics, Inc.
- Company CIK
- 0001346830
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 17,500
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 17,500
- Ownership description
- Not reported
- SEC acceptance time
- Dec 18, 2025, 5:00 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Conn Avi Daniel ↗
Chief Financial Officer
CIK 0002064982
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 17,500
- Conversion / exercise price
- 4.2
- Exercise date
- Not reported
- Expiration date
- December 16, 2035
Filing footnotes & remarks
- F1
- 25% of the shares subject to the option shall vest on December 16, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.